Serotonin-accumulating cells in the iris — ciliary body and cornea of various species

doi:10.1016/S0014-4835(87)80037-4

Experimental Eye Research

Volume 44, Issue 6, June 1987, Pages 731-745

https://doi.org/10.1016/S0014-4835(87)80037-4 Get rights and content

Serotonin was biochemically shown to be present in the iris — ciliary body of the frog, pigeon, goldfish and guinea-pig eyes at a concentration of between 55 and 95 ng per g. The aqueous fluid, in contrast, had no measurable serotonin, though a small amount of dopamine was present. Immunohistochemistry of the iris — ciliary body and cornea of all species failed to demonstrate the localization of serotonin. However, when tissues were first incubated with exogenous serotonin and then processed immunohistochemically for the localization of serotonin, positive staining was observed. Serotonin-accumulating fibres were present in the corneal stroma of the frog, pigeon and guinea-pig but not in the goldfish. In this species only a few unidentified nonneural cells in the corneal epithelium took up exogenous serotonin.

The evidence of serotonin-accumulating fibres in the frog, rat or goldfish iris — ciliary body complex was not conclusive. This contrasted with the pigeon iris — ciliary body where there were some delicate fibres in the epithelium layers which take up exogenous serotonin. It is however, in the guinea-pig iris — ciliary body that the serotonin-accumulating cells are most numerous with fibres being situated in the muscular and epithelial areas.

The distribution of tyrosine-hydroxylase immunoreactivity and serotonin-accumulating fibres in the guinea-pig iris — ciliary body was similar. The rat tissue also demonstrated a perfuse distribution of tyrosine-hydroxylase-positive fibres but lacked clear serotonin-accumulating fibres. The serotonin-accumulating fibres, therefore, do not give an indication of catecholaminergic fibres in all species.

References (15)

Nguyen-LegrosJ. et al.
Tyrosine hydroxylase-like immunoreactive interplexiform cells in the rat retina
Neurosci. Lett.
(1981)
OsborneN.N.
The occurrence of serotonergic nerves in bovine cornea
Neurosci. Lett.
(1983)
OsborneN.M. et al.
Postnatal development of serotonin-accumulating neurones in the rabbit retina and an immunohistochemical analysis of the uptake and release of serotonin
Exp. Eye Res.
(1984)
UusitaloH. et al.
Immunohistochemical and biochemical evidence for 5-hydroxytryptamine containing nerves in the anterior part of the eye
Exp. Eye Res.
(1982)
Boadle-BiberM.C.
Biosynthesis of serotonin
ConsolazioneA. et al.
Immunocytochemical detection of serotonin with monoclonal antibodies
J. Histochem. Cytochem.
(1981)
ChiouG.C.Y. et al.
Dopaminergic involvement in intraocular pressure in the rabbit retina
Ophthalmic Res.
(1982)

There are more references available in the full text version of this article.

Cited by (28)

Corneal nerves: Structure, contents and function
2003, Experimental Eye Research
This review provides a comprehensive analysis of the structure, neurochemical content, and functions of corneal nerves, with special emphasis on human corneal nerves. A revised interpretation of human corneal nerve architecture is presented based on recent observations obtained by in vivo confocal microscopy (IVCM), immunohistochemistry, and ultrastructural analyses of serial-sectioned human corneas. Current data on the neurotransmitter and neuropeptide contents of corneal nerves are discussed, as are the mechanisms by which corneal neurochemicals and associated neurotrophins modulate corneal physiology, homeostasis and wound healing. The results of recent clinical studies of topically applied neuropeptides and neurotrophins to treat neurotrophic keratitis are reviewed. Recommendations for using IVCM to evaluate corneal nerves in health and disease are presented.
[<sup>3</sup>H]-Serotonin release from bovine iris-ciliary body: Pharmacology of prejunctional serotonin (5-HT<inf>7</inf>) autoreceptors
2001, Experimental Eye Research
In the present study, we investigated the pharmacological characteristics of electrically stimulated [³H]-serotonin release from mammalian iris-ciliary bodies. Isolated bovine and human iris-ciliary bodies were loaded with [³H]-serotonin, superfused with Krebs buffer solution and then stimulated with trains of 300 direct current (d.c.) pulses to initiate the release of the transmitter. The modification of this [³H]-serotonin release process by various serotonergic agonists and antagonists was studied in order to define the pharmacology of serotonin receptor(s) present in the iris-ciliary body. In bovine iris-ciliary body, electrically-evoked [³H]-serotonin release was calcium-dependent, tetrodotoxin-sensitive and was enhanced by serotonin (EC₅₀ = 200 n $M$ ) and 5-carboxmidotryptamine (EC₅₀ = 4 n $M$ ). The rank order of potency of agonists in enhancing field-stimulated [³H]-serotonin release was: 5-carboamidotryptamine > m-chlorophenylbiguanide > 2-methyl-5-hydroxytryptamine = 5-methoxy-dimethyltryptamine > serotonin > 5-methoxy-tryptamine > L-694,247 = α-methyl-5-hydroxytryptamine > CGS 12066A = 8-hydroxy-2-(di- n -propylamino)tetraline. Serotonin and m-chlorophenylbiguanide also enhanced electrically-evoked [³H]-serotonin release from human iris-ciliary bodies with EC₅₀s of 3 μ $M$ and 30 n $M$ , respectively. The pharmacological profile displayed by serotonin receptor agonists was supported by the potent antagonism of the serotonin-induced enhancement of [³H]-serotonin release by 5HT₇receptor antagonists SB-258718 (IC₅₀ = 18.6 ± 1.2 n $M$ ;n = 4) and mesulergine (IC₅₀ = 0.26 ± 0.05 n $M$ ;n = 4). However, antagonists at 5HT₆and 5HT₃receptors exhibited a relatively weak blockade of serotonin induced enhancement of field-stimulated [³H]-serotonin release. These studies have shown the presence of functionally active prejunctional 5HT₇autoreceptors regulating the release of [³H]-serotonin from bovine iris-ciliary bodies. Excitatory prejunctional 5-HT autoreceptors also exist in human iris-ciliary bodies. It is possible that these serotonin autoreceptors may have relevance to the regulation of aqueous humor dynamics in the anterior uvea.
The 5-HT(1A) receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits
1999, Experimental Eye Research
The aims of this study were first to investigate the effect of topical instillation of the 5-HT_1Areceptor agonist 8-OH-DPAT on intraocular pressure (IOP) in normotensive rabbits and second to establish whether the drug reaches the aqueous humour of treated and contralateral eyes at concentrations sufficient to activate ciliary epithelial 5-HT_1Areceptors. Following topical unilateral instillation of (±), (+) or (-)8-OH-DPAT, the IOP of rabbits was measured using an applanation tonometer. For the penetration study, [³H]8-OH-DPAT was instilled into one eye of each rabbit. Animals were killed after 30 min and the radioactive content of treated and contralateral ocular tissues was assessed. Administration of (±)8-OH-DPAT caused dose-dependent decreases in IOP in treated eyes of rabbits during the light and dark. The full 5-HT_1Aagonist (+)8-OH-DPAT was shown to be a more effective hypotensive agent than the partial agonist (-)8-OH-DPAT. The effect of (±)8-OH-DPAT on IOP was blocked by pretreatment with pindolol, a mixed 5-HT_1Aantagonist/β-blocker, but not by the specific β-blocker betaxolol. After instillation of [³H]8-OH-DPAT, peak levels of radioactivity were found in the cornea, followed by similar amounts in the iris–ciliary body and aqueous. There was negligible radioactivity present in tissues of the contralateral eye. This study demonstrates that topical administration of the 5-HT_1Aagonist 8-OH-DPAT dose-dependently decreases IOP in normotensive rabbits during the light and dark. The action of 8-OH-DPAT is presumably local to the anterior uvea as IOP was reduced only in treated eyes and [³H]8-OH-DPAT failed to reach the contralateral eye after unilateral instillation. Moreover, since 5-HT_1Areceptors are located in the rabbit ciliary epithelium and the effect of 8-OH-DPAT is blocked by a recognized 5-HT_1Aantagonist, the mechanisms of action of 8-OH-DPAT may well involve a decreased secretion of aqueous humour.
Effect of oral ketanserin administration on intraocular pressure in glaucomatous patients
1991, Experimental Eye Research
We evaluated the effect of the antihypertensive drug ketanserin, a 5-HT antagonist, on intraocular pressure (IOP) in 20 patients with ocular hypertension, IOP, pupil diameter, systolic arterial pressure (SBP), diastolic arterial pressure (DBP) and heart rate (HR) were recorded at baseline and at 1-hr intervals for 3 hr after oral administration of 20 mg ketanserin or placebo, given in a randomized, double masked, cross-over fashion. The alternative treatment was given a week later.
In all patients, ketanserin significantly lowered IOP and SBP, while no variations in pupil diameter, DBP and HR were found. Moreover, after drug administration, total outflow facility, measured by conventional tonography, increased significantly.
These findings indicate that oral ketanserin could represent a new antiglaucomatous drug.
Nerve growth factor synthesis in cultured rat iris: Modulation by endogenous transmitter substances
1988, Experimental Cell Research
Organ cultures of rat iris show a characteristic change in the levels of both nerve growth factor (NGF) and its mRNA: a rapid but transient initial increase is followed by a smaller but persistently elevated NGF synthesis. This time course may be influenced by release of a factor(s) from degenerating nerve terminals and/or by the lack of some factor(s) repressing NGF synthesis in vivo. We therefore analyzed the influence of biogenic amine transmitter substances and putative neuropeptides on this elevation of NGF synthesis in cultured iris. The marked increase of NGF synthesis seen initially in culture was not completely mimicked by any of the substances tested. A specific increase in NGF production up to 150 % of control was observed only with cGMP. We also obtained some evidence that reaction to trauma following the culture procedure could enhance NGF production: cutting of hides into small pieces increased NGF production in culture up to 250% of control and, vice versa, treatment with 1 μM dexamethasone decreased NGF production to about 60 % of control. However, the sympathetic neurotransmitter norepinephrine (NE) decreased both NGF and its mRNA levels specifically in a dose-dependent manner (0.01-1 mM) to a minimum of about 25% of control. In situ hybridization with mRNA^NGF-specific probes showed that in cultures of dissociated iris cells all cells were capable of expressing mRNA^NGF, but that 0.1 mM NE preferentially decreased expression of mRNA^NGF in smooth muscle cells. Thus, our results indicate that the sympathetic transmitter NE is capable of downregulating NGF synthesis in the target cells of sympathetic neurons.
Immunomodulatory Role of Neuropeptides in the Cornea
2022, Biomedicines

View all citing articles on Scopus

View full text

Serotonin-accumulating cells in the iris — ciliary body and cornea of various species

Neurosci. Lett.

Neurosci. Lett.

Exp. Eye Res.

Exp. Eye Res.

Biosynthesis of serotonin

Immunocytochemical detection of serotonin with monoclonal antibodies

J. Histochem. Cytochem.

Dopaminergic involvement in intraocular pressure in the rabbit retina

Ophthalmic Res.